Related references
Note: Only part of the references are listed.Multi-Modal Single-Cell Sequencing Identifies Cellular Immunophenotypes Associated With Juvenile Dermatomyositis Disease Activity
Jessica Neely et al.
FRONTIERS IN IMMUNOLOGY (2022)
Single-cell profiling reveals distinct adaptive immune hallmarks in MDA5+dermatomyositis with therapeutic implications
Yan Ye et al.
NATURE COMMUNICATIONS (2022)
Gene Expression Profiles of Treatment Response and Non-Response in Children With Juvenile Dermatomyositis
Cory Stingl et al.
ACR OPEN RHEUMATOLOGY (2022)
Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis
Wanlong Wu et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)
Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Anais Nombel et al.
FRONTIERS IN IMMUNOLOGY (2021)
MDA5+ D Dermatomyositis Is Associated with Stronger Skin Type I Interferon Transcriptomic Signature with Upregulation of IFN-κ Transcript
Charle Cassius et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2020)
Anti-inflammatory, anti-oxidative stress and novel therapeutic targets for cholestatic liver injury
Yafei Zhang et al.
BIOSCIENCE TRENDS (2019)
Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation
Judith Wienke et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Nonclassical Monocytes in Health and Disease
Prakash Babu Narasimhan et al.
Annual Review of Immunology (2019)
A lineage-resolved molecular atlas of C. elegans embryogenesis at single-cell resolution
Jonathan S. Packer et al.
SCIENCE (2019)
The relationship between type 1 IFN and vasculopathy in anti-MDA5 antibody-positive dermatomyositis patients
Nobuyuki Ono et al.
RHEUMATOLOGY (2019)
ICAM3 mediates inflammatory signaling to promote cancer cell stemness
Wenzhi Shen et al.
CANCER LETTERS (2018)
Risk factors and disease mechanisms in myositis
Frederick W. Miller et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
Single-cell reconstruction of the early maternal-fetal interface in humans
Roser Vento-Tormo et al.
NATURE (2018)
Systemic and Tissue Inflammation in Juvenile Dermatomyositis: From Pathogenesis to the Quest for Monitoring Tools
Judith Wienke et al.
FRONTIERS IN IMMUNOLOGY (2018)
Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis
Yuichi Ishikawa et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review
Kun Chen et al.
JOURNAL OF AUTOIMMUNITY (2017)
Reversed graph embedding resolves complex single-cell trajectories
Xiaojie Qiu et al.
NATURE METHODS (2017)
Massively parallel digital transcriptional profiling of single cells
Grace X. Y. Zheng et al.
NATURE COMMUNICATIONS (2017)
IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis
Alain Meyer et al.
ACTA NEUROPATHOLOGICA (2017)
Egr-1 deficiency protects from renal inflammation and fibrosis
Li-Chun Ho et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
The physiological roles of ICAM-1 and ICAM-2 in neutrophil migration into tissues
Ruth Lyck et al.
CURRENT OPINION IN HEMATOLOGY (2015)
Serum cytokine profiles of patients with interstitial lung disease associated with anti-CADM-140/MDA5 antibody positive amyopathic dermatomyositis
Toshinori Takada et al.
RESPIRATORY MEDICINE (2015)
Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous
Ratnadeep Mukherjee et al.
SCIENTIFIC REPORTS (2015)
The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells
Cole Trapnell et al.
NATURE BIOTECHNOLOGY (2014)
Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease
Takahisa Gono et al.
RHEUMATOLOGY (2014)
Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse
Jinhyun Kim et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells
M. Nakano et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target
Clara Crescioli et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Interferon and Biologic Signatures in Dermatomyositis Skin: Specificity and Heterogeneity across Diseases
David Wong et al.
PLOS ONE (2012)
Long-term outcome in patients with juvenile dermatomyositis: a cross-sectional follow-up study
P. Mathiesen et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2012)
IRF7: activation, regulation, modification and function
S. Ning et al.
GENES AND IMMUNITY (2011)
Synergistic induction of CX3CL1 by interleukin-1β and interferon-γ in human lung fibroblasts: involvement of signal transducer and activator of transcription 1 signaling pathways
Takeo Isozaki et al.
TRANSLATIONAL RESEARCH (2011)
Type I interferon pathway in adult and juvenile dermatomyositis
Emily C. Baechler et al.
ARTHRITIS RESEARCH & THERAPY (2011)
ISG15 and immune diseases
Young Joo Jeon et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Interleukin-6 and Type I Interferon-Regulated Genes and Chemokines Mark Disease Activity in Dermatomyositis
Hatice Bilgic et al.
ARTHRITIS AND RHEUMATISM (2009)
Juvenile dermatomyositis: new developments in pathogenesis, assessment and treatment
Lucy R. Wedderburn et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2009)
Hsp60 in inflamed muscle tissue is the target of regulatory autoreactive T cells in patients with juvenile dermatomyositis
Elisabeth F. Elst et al.
ARTHRITIS AND RHEUMATISM (2008)
International consensus on a proposed score system for muscle biopsy evaluation in patients with juvenile dermatomyositis: A tool for potential use in clinical trials
Lucy R. Wedderburn et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity
Emily C. Baechler et al.
MOLECULAR MEDICINE (2007)
MxA gene expression in juvenile dermatomyositis peripheral blood mononuclear cells: Association with muscle involvement
Kevin A. O'Connor et al.
CLINICAL IMMUNOLOGY (2006)
Type I interferon-associated skin recruitment of CXCR3+lymphocytes in dermatomyositis
J Wenzel et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2006)
Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection
GA Kolumam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Interferon-α/β-mediated innate immune mechanisms in dermatomyositis
SA Greenberg et al.
ANNALS OF NEUROLOGY (2005)